Vumerity vs. Copaxone, Glatopa

• Are Vumerity and Copaxone, Glatopa the Same Thing?
• What Are Possible Side Effects of Vumerity?
• What Are Possible Side Effects of Copaxone, Glatopa?
• What Is Vumerity?
• What Is Copaxone, Glatopa?
• What Drugs Interact with Vumerity?
• What Drugs Interact with Copaxone, Glatopa?
• How Should Vumerity Be Taken?
• How Should Copaxone, Glatopa Be Taken?

Vumerity (diroximel fumarate) and Copaxone and Glatopa (glatiramer acetate) are used to treat multiple sclerosis (MS).

Vumerity is used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Copaxone and Glatopa are used to treat multiple sclerosis and to prevent relapse of MS.

Vumerity and Copaxone and Glatopa belong to different drug classes. Vumerity is an immunomodulator and Copaxone and Glatopa are combinations of four amino acids (proteins).

Side effects of Vumerity and Copaxone and Glatopa that are similar include nausea and vomiting.

Side effects of Vumerity that are different from Copaxone and Glatopa include flushing, abdominal pain, diarrhea, itching, rash, albumin in the urine, redness, and indigestion/heartburn.

Side effects of Copaxone and Glatopa that are different from Vumerity include injection site reactions (e.g., pain, redness, soreness, itching, swelling, or a hard lump), joint aches, body aches, neck pain, back pain, double vision, headache, increased urge to urinate, weakness, runny nose, swelling in your hands or feet, vaginal itching or discharge, fever, chills, flu symptoms, sore throat, and white patches or sores inside your mouth or on your lips.

Vumerity may interact with dimethyl fumarate.

Copaxone and Glatopa may interact with other drugs.

Common side effects of Vumerity include:

• flushing,
• abdominal pain,
• diarrhea,
• nausea,
• vomiting,
• itching,
• rash,
• albumin in the urine,
• redness, and
• indigestion/heartburn

Common side effects of Copaxone, Glatopa include:

• injection site reactions (e.g., pain, redness, soreness, itching, swelling, or a hard lump),
• nausea,
• vomiting,
• chills,
• joint aches,
• body aches,
• neck pain,
• back pain,
• double vision,
• headache,
• increased urge to urinate,
• weakness,
• runny nose,
• swelling in your hands or feet,
• vaginal itching or discharge,
• fever,
• chills,
• flu symptoms,
• sore throat, or
• white patches or sores inside your mouth or on your lips.

Immediately after injection with Copaxone, you may experience:

• flushing (warmth, redness, or tingly feeling),
• chest pain,
• fast heartbeat,
• anxiety,
• shortness of breath, or
• itching.

These symptoms usually disappear quickly and usually do not require treatment. Tell your doctor if you have serious side effects of Copaxone including:

• dizziness,
• fainting,
• infection (such as fever, persistent sore throat),
• mental/mood changes (such as depression),
• severe pain at the injection site,
• shakiness (tremor), or
• vision problems.

Vumerity (diroximel fumarate) is an immunomodulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Copaxone, Glatopa (glatiramer acetate) are a combination of four amino acids (proteins) used to treat multiple sclerosis (MS) and to prevent relapse of MS. Copaxone will not cure MS, but it can make relapses occur less often.

Vumerity may interact with other medicines such as:

• dimethyl fumarate

Tell your doctor all medications and supplements you use.

There may be other drugs that can interact with Copaxone, Glatopa. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. During pregnancy, Copaxone should be used only when prescribed. It is not known if this drug passes into breast milk. Consult your doctor before breastfeeding.

The starting dose of Vumerity is 231 mg twice a day, orally, for 7 days. The maintenance dose of Vumerity after 7 days is 462 mg (administered as two 231 mg capsules) twice a day, orally.

Copaxone is injected subcutaneously (just beneath the skin) in a dose of 20 mg/day.